Taken together, these observations suggest that the downregulation of CEBPα is essential for RANBP2-associated O-glycosylation imbalance and the HCC malignant phenotype in vitro with respect to higher proliferation and invasion as well as less apoptosis. The gene discussed is CEBPA; the disease is hepatocellular carcinoma.